Who Owns AnaptysBio Stock?
NASDAQ: ANABHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 107.28%
- Institutions (% of float)
- 113.71%
- Held by insiders
- 5.66%
- Institutional holders
- 318
- Institutions 94.3%
- Insiders 5.7%
- Public and other 0.0%
Who owns AnaptysBio stock?
Institutional investors own about 107.3% of AnaptysBio's shares, spread across 318 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 5.66% of ANAB.
The largest institutional holders are EcoR1 Capital, LLC (26.51%), Blackrock Inc. (6.36%) and Tang Capital Management, LLC (4.96%). Together, the top 10 institutions control 58.3% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their ANAB positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ANAB
| Institution | Shares | % Held | Change |
|---|---|---|---|
| EcoR1 Capital, LLC | 7.88M | 26.51% | 0.0% |
| Blackrock Inc. | 1.89M | 6.36% | +2.6% |
| Tang Capital Management, LLC | 1.47M | 4.96% | +10.8% |
| State Street Corporation | 1.15M | 3.85% | -10.9% |
| Vanguard Capital Management LLC | 909.95K | 3.06% | +0.4% |
| Goldman Sachs Group Inc | 850.34K | 2.86% | +45.6% |
| Sanofi | 821.92K | 2.76% | 0.0% |
| Shaw D.E. & Co., Inc. | 819.59K | 2.76% | +51.9% |
| Millennium Management Llc | 807.32K | 2.72% | +69.8% |
| 683 Capital Management LLC | 740.00K | 2.49% | +12.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ANAB
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 648.15K | 2.18% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 640.36K | 2.15% |
| iShares Trust-iShares Russell 2000 ETF | 522.21K | 1.76% |
| TIAA-CREF Funds-Nuveen Quant Small Cap Equity Fund | 263.84K | 0.89% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 237.03K | 0.80% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 216.22K | 0.73% |
| iShares Trust-iShares Biotechnology ETF | 215.70K | 0.73% |
| Federated Hermes Equity Funds-Federated Hermes Kaufmann Small Cap Fund | 210.00K | 0.71% |
| Victory Portfolios III-Victory Science & Technology Fund | 187.89K | 0.63% |
| Invesco Exchange-Traded Fund Trust-Invesco Biotechnology & Genome ETF | 187.47K | 0.63% |
Frequently asked questions
Who is the largest shareholder of AnaptysBio?
EcoR1 Capital, LLC is the largest institutional shareholder of ANAB, owning 26.51% of shares outstanding (7.88M shares) as of its latest 13F filing.
What percentage of AnaptysBio is owned by institutions?
Institutions own about 107.3% of ANAB shares and 113.7% of the public float.
How much of AnaptysBio do insiders own?
Insiders, such as officers and directors, own about 5.66% of ANAB shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.